How Med Spas Can Advertise Before-and-After Results Within the FTC Guides

Before-and-after photos are conditioned, not banned

Nothing in the Endorsement Guides forbids showing a result. The Guides govern the claim an image implies, which is that a prospective patient can expect something similar. Where that is not true, the answer is disclosure of the generally expected outcome rather than removal of the photograph.

Start with what the Guides are, because it changes how to read everything written about them. Section 255.0 describes them as administrative interpretations that provide the basis for voluntary compliance with section 5 of the FTC Act³. They are not regulations. Practices inconsistent with them may lead to corrective action under section 5, which is the real legal hook, so this is not a reason to relax. It is a reason to be precise, and to be sceptical of any article telling you the FTC "requires" something under the Guides.

What the Guides actually address is the implied claim. An endorsement featuring a specific result is generally read to mean the endorser's experience reflects what others can also expect. So a striking result posted without context is not a photograph in the eyes of the framework; it is a performance claim. That is the whole of the issue, and it is why the fix is contextual rather than a matter of deleting your gallery.

The practical consequence for a med spa is that your best outcomes are still usable. You simply cannot present an exceptional outcome as though it were the ordinary one. Most of the compliance work is therefore about what sits next to the image rather than about the image itself.

What the Guides actually ask for: substantiation, typicality, disclosure

Three obligations sit behind results advertising. Hold proof for the claim being made, including scientific evidence where appropriate. Where the depicted result is not representative, clearly and conspicuously disclose what consumers generally achieve. And disclose any material connection the audience would not expect.

On substantiation, section 255.2 says advertisers should possess substantiation for claims conveyed by an endorsement, including competent and reliable scientific evidence where appropriate³. In practice that means you should be able to explain, before publishing, what evidence supports the outcome the images imply and over what number of patients and what timeframe.

On typicality, the same section says that where an endorser's experience is not representative of what consumers will generally achieve, the advertisement should clearly and conspicuously disclose the generally expected performance in the depicted circumstances, and the advertiser should have substantiation for that disclosure too³. That last clause is the one people miss. You need evidence for the typical result, not just a sentence claiming one.

On disclosure of connections, section 255.5 addresses material connections between an endorser and the advertiser, called for where the audience would not reasonably expect the relationship, and specifically where a significant minority of the audience would not understand it³. Helpfully, it does not demand you publish commercial details. It asks for enough to communicate the nature of the connection so a consumer can weigh the endorsement properly.

This guide is general compliance education from a marketing agency, and it is not legal advice. It describes federal FTC materials and does not attempt any state-law overlay. If you are making specific claims about a treatment, have them reviewed by a qualified attorney before publishing. If the marketing side is what you need help with, our med spa SEO work is built around claims that can survive this kind of scrutiny, and you can ask us what we would and would not publish for you.

Why a generic disclaimer alone does not solve the typicality problem

The "results not typical" safe harbor was removed in 2009, not 2023. Under the 1980 Guides, an unusual result could be shown with such a disclaimer. The revised Guides removed that automatic protection, on the Commission's view that a generic line does not change what a consumer takes away.

The date matters because so much published advice gets it wrong. The revised Guides appeared at 74 FR 53124 and took effect on 1 December 2009⁴. That is when the safe harbor went. The 2023 revision, published at 88 FR 48092 and effective 26 July 2023, is the most recent edit to the same Guides³, not the moment the disclaimer stopped working. If an article dates the change to 2023, it is fourteen years late, which tells you how carefully the rest of it was researched.

Now the correction that runs the other way, because the myth cuts both directions. The 2009 notice says plainly that the revised Guides would not prohibit the use of disclaimers of typicality⁴. Disclaimers are permitted. What the Commission removed was their automatic protective effect, having expressed doubt that a generic line changes consumer takeaway. So "the FTC banned disclaimers" is as wrong as "a disclaimer makes it fine".

The accurate formulation is narrow and worth memorising: a generic disclaimer alone does not cure a claim of atypical results. The Guides leave two workable routes, which is what the 2009 notice describes. Either hold substantiation that the depicted experience is representative, or clearly and conspicuously disclose the generally expected performance and hold substantiation for that⁴.

For a med spa that translates into something concrete. Replace "results may vary" with what the typical patient can actually expect, in the same visual weight as the claim itself, based on evidence you hold. It is more work than a footer line, and it is also considerably more persuasive to a sceptical buyer than a disclaimer nobody believes.

Testimonials, influencers, and material connections

Any endorsement from someone connected to you carries a disclosure question: staff, family, a patient given a discounted or free treatment, or an influencer being paid. The test is whether the audience would expect the relationship, and disclosure should be clear enough to communicate its nature.

Section 255.5 frames this around audience expectation rather than around payment specifically, which is broader than most people assume³. A gifted treatment counts. A staff member counts. A friend of the owner counts. The question is not whether money changed hands but whether a reasonable viewer would understand the relationship, and disclosure is called for where a significant minority would not.

There is a separate and harder-edged instrument sitting next to the Guides now, and the distinction matters. The FTC rule on the use of consumer reviews and testimonials, 16 CFR Part 465, effective 21 October 2024, is a binding rule rather than an interpretation. It prohibits fake or false consumer reviews and testimonials, buying positive or negative reviews, and undisclosed insider reviews, requiring owners, officers, managers, employees and their relatives to clearly disclose their relationship⁵.

So for a med spa the practical division is this. How you present a genuine patient result is governed by the Guides, which are interpretive. Whether the review or testimonial is genuine at all, and whether insiders disclose, sits under a binding rule. The second category is where the sharper legal exposure lives, and it is also the easier one to comply with, because it asks only for honesty and a sentence of disclosure. We covered the same discipline on the review side in how to earn Google reviews without breaking the FTC rules.

• Disclose staff, family and owner relationships in any testimonial or before-and-after feature.
• Disclose gifted, discounted or comped treatments, not only cash payments.
• Place the disclosure where the endorsement is, not in a footer or a linked page.
• Keep signed consent for every patient image you publish, separately from the compliance question.
• Never publish a testimonial you cannot trace to a real, identifiable patient.

The enforcement myth worth retiring

Med spa marketing articles frequently warn about FTC enforcement over before-and-after photos. We could find no public record of such an action. The med spa warning letters that surface in searches are COVID-19 claims letters from 2020 and 2021, which concerned disease claims rather than results advertising.

This one is worth being careful about in both directions. We are not asserting that no such action exists anywhere; that would be proving a negative. What we can say is that we looked for the public record behind the claim and did not find one, and that the med spa letters which do surface concern COVID-19 treatment claims from 2020 and 2021, a different subject entirely.

The reason to correct it is not pedantry. Fear-based compliance advice tends to produce the wrong response, which is usually removing all results marketing rather than fixing how it is presented. A med spa that deletes its gallery because of an enforcement story that nobody can source has given up its most persuasive asset for no reason, while leaving the actual issues, substantiation and disclosure, untouched.

The genuinely useful posture is to take the primary record seriously and the marketing folklore lightly. The Guides are interpretive but sit on top of section 5 liability³. The reviews rule is binding⁵. Those two facts justify doing this properly without needing an invented enforcement story to motivate it.

A note on how to read any compliance article, including this one. Check whether it cites the Federal Register or the CFR directly, and whether the dates match. On this topic the fastest tell is the safe harbor date: an article saying 2023 rather than 2009 has not read the source.

How to advertise med spa results safely

The workable version is a short standard applied consistently: publish results you can substantiate, state the generally expected outcome beside the exceptional one, disclose every connection, and keep consent and evidence on file. None of it requires giving up your best cases.

Build the evidence before the campaign rather than after a complaint. For each treatment you advertise, write down what a typical course of treatment produces, over what timeframe, across how many patients, and what evidence supports that. If you cannot complete that sentence, you are not ready to advertise the outcome, and that is a useful gate rather than an obstacle.

Then fix the presentation. Standardize photography so the comparison is honest, meaning consistent lighting, angle, distance and interval, since an inconsistent pair can imply a result the treatment did not produce. Put the expected-outcome statement adjacent to the images in comparable visual weight, not in a footer. Disclose connections inline. Keep written consent for every image.

Finally, review it on a schedule. This is an area where the record moves: the Guides were revised in 2009⁴ and again in 2023³, and a binding reviews rule arrived in 2024⁵. A yearly review of your claims against the current primary sources is proportionate, and it is far cheaper than discovering a problem through a complaint.

1. Define the typical result first. For each advertised treatment, document the generally expected outcome, the timeframe and the evidence behind it.
2. Standardize the photography. Same lighting, angle, distance and time interval, so the comparison reflects the treatment rather than the camera.
3. Put the expected outcome next to the exceptional one. Clear and conspicuous means comparable prominence, not a footer line.
4. Disclose every connection inline. Staff, family, gifted or discounted treatment, paid influencer. At the endorsement, not on a separate page.
5. Keep consent and substantiation on file. Written patient consent for each image, and the evidence supporting your typical-result statement.
6. Review annually against primary sources. The Guides changed in 2009 and 2023, and a binding reviews rule took effect in 2024.